{
    "nctId": "NCT05825482",
    "briefTitle": "Breast Margin Study: Routine Cavity Shave Margins Vs. Selective Margins Using Savi Scout\u00ae",
    "officialTitle": "Breast Margin Study: Routine Cavity Shave Margins Vs. Selective Margins Using Savi Scout\u00ae",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 204,
    "primaryOutcomeMeasure": "Determine the difference in positive margin rate between the two methods.",
    "eligibilityCriteria": "Inclusion Criteria\n\n* Women 18 years and older, and\n* With Clinical stage I-II invasive breast cancer, or Stage 0 DCIS, and\n* That have been diagnosed by means of core needle biopsy appropriate for breast conserving therapy, and\n* Present to Cleveland Clinic Akron General.\n* Subjects must have pathologically confirmed breast carcinoma or ductal carcinoma in situ.\n* Performance status: ECOG 0-1\n* Subjects must have the ability to understand and the willingness to sign a written informed consent document.\n* Patients may have received or may be receiving endocrine therapy.\n\nExclusion Criteria\n\n* Men\n* Pregnant women\n* Patients who have received neoadjuvant chemotherapy for current cancer diagnosis.\n* Patients with current diagnosis of synchronous bilateral breast cancer. (A diagnosis of breast cancer at least one year prior to current cancer diagnosis is acceptable.)\n* Patients \\< 18 years of age.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}